Publications by authors named "Yared Hailemichael"

Claim this Profile
L
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade.
Amber Hickman, Joost Koetsier, Trevin Kurtanich, Michael C Nielsen, Glenn Winn, Yared Hailemichael

J Clin Invest· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.
Yared Hailemichael, Daniel H Johnson, Noha Abdel-Wahab, Wai Chin Foo, Salah-Eddine Bentebibel

Cancer Cell· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies.
Sruthy Varghese, Snigdha Pramanik, Leila J Williams, Hannah R Hodges, Courtney W Hudgens, Yared Hailemichael

Mol Cancer Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy.
Meenu Sharma, Hiep Khong, Faisal Fa'ak, Salah-Eddine Bentebibel, Louise M E Janssen, Yared Hailemichael

Nat Commun· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma.
Xiaohui Zhang, Hans C Lee, Fazal Shirazi, Veerabhadran Baladandayuthapani, Heather Lin, Yared Hailemichael

Leukemia· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccinating with Stem Cells to Stop Cancer.
Yared Hailemichael, Manisha Singh, Willem Overwijk

Trends Mol Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8 T Cell Response.
Hiep Khong, Annika Volmari, Meenu Sharma, Zhimin Dai, Chinonye S Imo, Yared Hailemichael

J Immunol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy.
Yared Hailemichael, Amber Woods, Tihui Fu, Qiuming He, Michael C Nielsen

J Clin Invest· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression.
Heather J Dalton, Sunila Pradeep, Michael McGuire, Yared Hailemichael, Shaolin Ma

Clin Cancer Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.
Manisha Singh, Christina Vianden, Mark J Cantwell, Zhimin Dai, Zhilan Xiao, Yared Hailemichael

Nat Commun· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model.
Cara L Haymaker, Yared Hailemichael, Yi Yang, Roza Nurieva

J Vis Exp· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifaceted Role of BTLA in the Control of CD8 T-cell Fate after Antigen Encounter.
Krit Ritthipichai, Cara L Haymaker, Melisa Martinez, Andrew Aschenbrenner, Xiaohui Yi, Yared Hailemichael

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of Grail promotes CD8 T cell anti-tumour activity.
Cara Haymaker, Yi Yang, Junmei Wang, Qiang Zou, Anupama Sahoo, Yared Hailemichael

Nat Commun· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble interleukin-15 complexes are generated in vivo by type I interferon dependent and independent pathways.
Scott M Anthony, Megan E Howard, Yared Hailemichael, Willem W Overwijk, Kimberly S Schluns

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse model for pre-clinical study of human cancer immunotherapy.
Zhiya Ya, Yared Hailemichael, Willem Overwijk, Nicholas P Restifo

Curr Protoc Immunol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccination.
Yared Hailemichael, Willem W Overwijk

Int J Biochem Cell Biol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice.
Hong Qin, Beatrisa Lerman, Ippei Sakamaki, Guowei Wei, Soungchul C Cha, Yared Hailemichael

Nat Med· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide-based anticancer vaccines: The making and unmaking of a T-cell graveyard.
Yared Hailemichael, Willem W Overwijk

Oncoimmunology· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion.
Yared Hailemichael, Zhimin Dai, Nina Jaffarzad, Yang Ye, Miguel A Medina

Nat Med· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.
Padmini Jayaraman, Falguni Parikh, Esther Lopez-Rivera, Yared Hailemichael, Amelia Clark

J Immunol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conference scene: immune effector mechanisms in tumor immunity.
Andrew G Sikora, Yared Hailemichael, Willem W Overwijk

Immunotherapy· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity mediated by CpG: the route of administration is critical.
Yanyan Lou, Chengwen Liu, Gregory Lizée, Weiyi Peng, Chunyu Xu, Yared Hailemichael

J Immunother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.
Ling-Yuan Kong, Alexander Gelbard, Jun Wei, Chantal Reina-Ortiz, Yongtao Wang, Yared Hailemichael

Clin Cancer Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy.
Andrew G Sikora, Alexander Gelbard, Michael A Davies, Daisuke Sano, Suhendan Ekmekcioglu, Yared Hailemichael

Clin Cancer Res· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity.
Andrew G Sikora, Nina Jaffarzad, Yared Hailemichael, Alexander Gelbard, Spencer W Stonier

J Immunol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis